Nationwide
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant
Novartis Pharmaceuticals
Ph 1·~8yr·6 sites in CA, KS, PA +2
Showing 1–24 of 557 trials
Novartis Pharmaceuticals
BioNTech SE
Mabwell (Shanghai) Bioscience Co., Ltd.
H. Lee Moffitt Cancer Center and Research Institute
Qurgen Inc.
Iambic Therapeutics, Inc
Jazz Pharmaceuticals
Processa Pharmaceuticals
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Edgewood Oncology Inc.
Clasp Therapeutics, Inc.
Daiichi Sankyo
Halda Therapeutics OpCo, Inc.
Eli Lilly and Company
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
858 Therapeutics, Inc.